Your session is about to expire
← Back to Search
Neutron Radiation + Pembrolizumab for Bladder Cancer
Study Summary
This trial is studying how well neutron radiation therapy and pembrolizumab work to treat urothelial carcinoma that has spread to other parts of the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am eligible for immunotherapy with pembrolizumab.My cancer is confirmed to be urothelial carcinoma.I have signed the consent form for this study.My liver enzymes are within the required limits, even with liver metastasis.I can take care of myself and am up more than 50% of my waking hours.My kidney function, measured by creatinine, is within the normal range.My blood clotting time is normal or managed if I'm on blood thinners.I have at least two tumors that can be measured.I haven't taken steroids in the last 2 weeks and don't expect to need them during the study.I have been treated with drugs targeting PD-1, PD-L1, or PD-L2.I have been diagnosed with HIV.I have or had lung inflammation not caused by an infection.I have treated brain metastases with no new growth and haven't used steroids in the last 7 days.I can receive neutron radiation for up to 3 cancer spread sites.I am currently being treated for an infection.I have never needed treatment for an autoimmune disease.My kidney function, measured by creatinine, is within the normal range.My blood clotting time is normal or managed with medication.I have an active tuberculosis infection.My liver enzymes are within the required range.My blood clotting time is normal or managed with medication.I am eligible for immunotherapy with pembrolizumab.I have not received a live vaccine in the last 30 days.My blood clotting time is normal or managed if I'm on blood thinners.I have another cancer that is getting worse or needs treatment.My cancer is confirmed to be urothelial carcinoma.I can have neutron radiation for up to 3 cancer spread sites.I haven't taken steroids for 2 weeks and don't expect to need them during the study.I have signed the consent form for this study.I have at least two tumors that can be measured.I have never needed treatment for an autoimmune disease.I can take care of myself and am up and about more than 50% of my waking hours.
- Group 1: Treatment (Pembrolizumab, neutron radiation therapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please provide me with an overview of the previous experiments conducted on Pembrolizumab?
"Currently, 961 clinical studies involving Pembrolizumab are active. Of those live trials, 122 have reached Phase 3 of testing. Houston is the epicentre for the majority of these tests; however there are 35,727 international sites offering this treatment protocol."
What is the scope of participation in this clinical experiment?
"Affirmative. Clinicaltrials.gov's data reveals that this study, launched on January 17th 2019, is actively looking for participants. Specifically, 20 patients must be recruited from a singular clinical site."
To what maladies is Pembrolizumab most commonly administered?
"Pembrolizumab has been used to treat malignant neoplasms, unresectable melanomas, and cases of microsatellite instability high."
Does the FDA accept Pembrolizumab as a therapeutic measure?
"After careful assessment, the safety of pembrolizumab was judged to be a 2 out of 3. This is because this phase 2 trial has evidence in favor of its safety but no proof that it's effective yet."
Is enrollment still open for this medical trial?
"According to clinicaltrials.gov, this research venture is currently seeking trial participants. The initial listing was published on the 17th of January 2019 and recently amended on the 21st of June 2022."
Share this study with friends
Copy Link
Messenger